Foot/Ankle News

The FDA announced approval of the Patient Specific Talus Spacer, a “first-of-its-kind” 3D-printed implant for talus replacement surgery in patients with avascular necrosis, according to a press release.

A 68-year-old man presented to our outpatient orthopedic department with a complicated history of chronic ankle pain and deformity, as well as a right ankle injury sustained 3 weeks earlier.

A collaborative care model that utilizes buprenorphine-waivered physicians and community pharmacists was associated with high rates of opioid use disorder treatment retention and adherence, results of a pilot study showed.

Published results showed HTX-011 may lead to mild postoperative pain scores and reduced opioid use after bunionectomy.

Patients who used cannabis and underwent opioid agonist therapy in Vancouver had a significantly lower risk of being exposed to fentanyl, according to a study published in Drug and Alcohol Dependence.

DJO LLC has announced the acquisition of Trilliant Surgical, an orthopedic foot and ankle implant provider, according to a press release.

Through modern implants and improved surgical techniques, surgeons are able to achieve improved outcomes with total ankle arthroplasty, including in patients with increasing levels of foot and ankle deformity.

HHS has released new guidance that the agency said will improve access to medication-assisted treatment for opioid use disorder.

Carbon22, a company of GLW Inc., has received FDA 510(k) clearance to market the Creed cannulated screw system, a series of ortholucent bone screws for use in foot and ankle surgery, according to a press release.

Regular intake of glucosamine/chondroitin was associated with lower all-cause and CVD mortality among adults aged older than 40 years in the United States, data from a cohort study showed.